Ardelyx News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.12.21	Pre-market Movers: OP, SLHG, ARDX, WORX, LGVN… (RTTNews)
30.11.21	Ardelyx Launching IBSRELA® Second Quarter of 2022 (PR Newswire)
12.11.21	Ardelyx Reports Third Quarter 2021 Financial Results (PR Newswire)
11.11.21	Ardelyx to Present at the Jefferies London Healthcare Conference (PR Newswire)
05.11.21	Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021 (PR Newswire)
04.11.21	Ardelyx to Pursue Formal Dispute Resolution for Tenapanor (PR Newswire)
29.10.21	Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021 (PR Newswire)
13.10.21	Ardelyx Awaiting Next Steps From FDA To Resubmit NDA For Tenapanor For Hyperphosphatemia (RTTNews)
13.10.21	Ardelyx Provides Corporate Update Following Type A Meeting with FDA (PR Newswire)
22.09.21	ARDX DEADLINE ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action ... (PR Newswire)
16.09.21	ARDX NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action ... (PR Newswire)
03.09.21	Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial (PR Newswire)
26.08.21	ARDX NOTICE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action... (PR Newswire)
20.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadline - ARDX (PR Newswire)
17.08.21	Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Ardelyx Inc. (ARDX) (PR Newswire)
13.08.21	Ardelyx Reports Second Quarter 2021 Financial Results (PR Newswire)
13.08.21	Pomerantz Law Firm Announces the Filing of a Class Action Against Ardelyx, Inc. and Certain Officers - ARDX (PR Newswire)
12.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX (PR Newswire)
04.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX (PR Newswire)
03.08.21	ARDX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Ardelyx, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm (PR Newswire)
02.08.21	ARDX INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. (PR Newswire)
29.07.21	Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis (PR Newswire)
29.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX (PR Newswire)
21.07.21	Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc. (PR Newswire)
21.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX (PR Newswire)
20.07.21	(ARDX) Alert: Johnson Fistel, Investigates Ardelyx Following FDA Notification. Did You Lose Money on Your Ardelyx Investment? (PR Newswire)
19.07.21	Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis (PR Newswire)
24.06.21	Biotech Stocks Facing FDA Decision In July 2021 (RTTNews)
27.03.21	Biotech Stocks Facing FDA Decision In April 2021 (RTTNews)
16.09.20	ARPO To Report Glaucoma Trial Data In Q4, ARDX To Face FDA In April, PFE's Pipeline Update (RTTNews)
15.09.20	Stock Alert: Ardelyx Down 6% (RTTNews)
04.12.19	ARDX Jumps On PHREEDOM Data, AXSM Is Awesome, CARA On Watch (RTTNews)
27.11.19	5 Top Gainers In Healthcare Sector (HEPA, ARDX, PTI...) (RTTNews)
04.10.19	New Drugs Approved In September (RTTNews)
10.09.19	6 Top Gainers In Healthcare Sector (ACAD, ARDX, KOOL…) (RTTNews)
04.09.19	Two Down, Two To Go For Ardelyx (RTTNews)
04.09.19	5 Top Gainers In Healthcare Sector (ARDX, CDTX, EBS...) (RTTNews)
03.09.19	Ardelyx: AMPLIFY Study Meets Primary, All Key Secondary Endpoints - Quick Facts (RTTNews)
26.08.19	Biotech Stocks Facing FDA Decision In September 2019 (RTTNews)
20.08.19	5 Top Gainers In Healthcare Sector (TROV, FULC, ARDX…) (RTTNews)
04.07.18	AVXL On Track, JNP Snapped Up, BLFS Hits New High, VRAY Catches Eyes (RTTNews)
29.05.18	Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference (PR Newswire)
21.05.18	Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank (PR Newswire)
08.05.18	Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights (PR Newswire)
04.04.18	MACH Energy Earns 2018 ENERGY STAR® Award For Excellence (PR Newswire)
19.03.18	Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada (PR Newswire)
14.03.18	Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors (PR Newswire)
12.02.18	Ardelyx Announces Departure of Chief Scientific Officer (PR Newswire)
08.02.18	Ardelyx to Participate in Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
03.01.18	Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ardelyx Inc

Aktien Top/Flop

Meistgelesene Nachrichten